AMEDISYS, INC. (NASDAQ:AMED) Files An 8-K Regulation FD Disclosure

ITEM7.01.

As of March21, 2017 representatives of Amedisys, Inc. (the
Company) will begin making presentations at investor conferences
using slides containing the information attached to this Current
Report on Form 8-K as Exhibit 99.1. The Company expects to use
these slides, in whole or in part, and possibly with
modifications, in connection with presentations to investors,
analysts and others during 2017.

By filing this report on Form 8-K and furnishing this
information, the Company makes no admission as to the materiality
of any information in this report that is required to be
disclosed solely by reason of Regulation FD.

The information contained in the slides is summary information
that is intended to be considered in the context of the Companys
Securities and Exchange Commission (SEC) filings and other public
announcements that it may make, by press release or otherwise,
from time to time. The Company undertakes no duty or obligation
to publicly update or revise the information contained in this
report, although it may do so from time to time as its management
believes is warranted. Any such updating may be made through the
filing of other reports or documents with the SEC, through press
releases or through other public disclosure.

In accordance with General Instruction B.2 of this Current Report
on Form 8-K, the information presented herein shall not be deemed
filed for purposes of Section18 of the Securities Exchange Act of
1934, as amended, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933, as
amended, except as previously set forth by specific reference in
such a filing.

Use of our Website to Distribute Material Company
Information

Our company website address is www.amedisys.com. We use our
website as a channel of distribution for important company
information. Important information, including press releases,
analyst presentations and financial information regarding our
company, is routinely posted on and accessible on the Investor
Relations subpage of our website, which is accessible by clicking
on the tab labeled Investors on our website home page. Visitors
to our website can also register to receive automatic e-mail and
other notifications alerting them when new information is made
available on the Investor Relations subpage of our website.

Certain Forward-Looking Statements

When included in this press release, words like believes, belief,
expects, plans, anticipates, intends, projects, estimates, may,
might, would, should and similar expressions are intended to
identify forward-looking statements as defined by the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements involve a variety of risks and uncertainties that
could cause actual results to differ materially from those
described therein. These risks and uncertainties include, but are
not limited to the following: changes in Medicare and other
medical payment levels, our ability to open care centers, acquire
additional care centers and integrate and operate these care
centers effectively, changes in or our failure to comply with
existing federal and state laws or regulations or the inability
to comply with new government regulations on a timely basis,
competition in the healthcare industry, our ability to integrate
our personal care segment into our business efficiently, changes
in the case mix of patients and payment methodologies, changes in
estimates and judgments associated with critical accounting
policies, our ability to maintain or establish new patient
referral sources, our ability to attract and retain qualified
personnel, changes in payments and covered services due to the
economic downturn and deficit spending by federal and state
governments, future cost containment initiatives undertaken by
third-party payors, our access to financing, our ability to meet
debt service requirements and comply with covenants in debt
agreements, business disruptions due to natural disasters or acts
of terrorism, our ability to integrate, manage and keep our
information systems secure, our ability to comply with
requirements stipulated in our corporate integrity agreement and
changes in law or developments with respect to any litigation
relating to the Company, including various other matters, many of
which are beyond our control.

Because forward-looking statements are inherently subject to
risks and uncertainties, some of which cannot be predicted or
quantified, you should not rely on any forward-looking statement
as a prediction of future events. We expressly disclaim any
obligation or undertaking and we do not intend to release
publicly any updates or changes in our expectations concerning
the forward-looking statements or any changes in events,
conditions or circumstances upon which any forward-looking
statement may be based, except as required by law.

2

SECTION9 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits.

3

About AMEDISYS, INC. (NASDAQ:AMED)

Amedisys, Inc. (Amedisys) is a provider of home health and hospice services. The Company offers home health services to the chronic, co-morbid, aging American population. The Company operates through three segments: home health, hospice and personal care. The Company’s home health segment delivers a range of services in the homes of individuals recovering from surgery, have a chronic disability or terminal illness or need assistance with completing important personal tasks. The Company’s hospice segment provides palliative care and comfort to terminally ill patients and their families. The Company’s personal care segment provides patients with assistance with the essential activities of daily living. The Company owns and operates approximately 330 Medicare-certified home healthcare centers, over 80 Medicare-certified hospice care centers and approximately nine personal-care care centers in over 30 states within the United States, the District of Columbia and Puerto Rico.

AMEDISYS, INC. (NASDAQ:AMED) Recent Trading Information

AMEDISYS, INC. (NASDAQ:AMED) closed its last trading session 00.00 at 50.25 with 251,032 shares trading hands.